GenRx Alendronate Plus D3 70 mg/140 ug alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

colecalciferol, Quantity: 140 microgram; alendronate sodium, Quantity: 91.37 mg

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

alendronate sodium,colecalciferol

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Excipient Ingredients: magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; mannitol; hypromellose; butylated hydroxytoluene

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

4

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Alendronate Plus D 70 mg/70 ?g and Alendronate Plus D 70 mg/140 ?g tablets are indicated for the treatment of:,Osteoporosis in select patients where vitamin D supplementation is recommended.,Prior to treatment, osteroporosis must be confirmed by:,The finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by,The presence of osteoporotic fracture

Sommarju tal-prodott:

Visual Identification: White to off-white, rectangular, biconvex tablet. Engraved APO on one side, ALE-D56 on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2014-12-17